Analysis of p53 expression in human tumours: an antibody raised against human p53 expressed in Escherichia coli
- PMID: 1569122
- DOI: 10.1242/jcs.101.1.183
Analysis of p53 expression in human tumours: an antibody raised against human p53 expressed in Escherichia coli
Abstract
A cDNA encoding the complete normal human p53 protein was expressed in Escherichia coli using an expression system based on the bacteriophage T7 promoter. The cDNA was adapted so that the full-length protein was produced without fusion to any other sequence. Large amounts of the protein were isolated and the purified protein used to produce very high titre polyclonal antibodies to p53. These new antibodies permit the sensitive detection of p53 and p53 complexes in ELISA and immunoblotting assays. Most importantly, they also permit the detection of p53 in archival tumour material that has been conventionally fixed in formalin and embedded in paraffin wax. Using this reagent we have found that aberrant expression of p53 is a frequent feature of human breast cancer. We are able to recognise six different classes of p53 expression pattern that may be of help in the subclassification of breast tumours.
Similar articles
-
Abnormalities of the p53 tumour suppressor gene in human pancreatic cancer.Br J Cancer. 1991 Dec;64(6):1076-82. doi: 10.1038/bjc.1991.467. Br J Cancer. 1991. PMID: 1764370 Free PMC article.
-
Studies on p53 immunolocalisation in breast cancer and its prognostic significance.Hum Antibodies. 1999;9(3):171-6. Hum Antibodies. 1999. PMID: 10690631
-
Production of a polyclonal antibody raised against recombinant flounder p53 protein.Comp Biochem Physiol C Pharmacol Toxicol Endocrinol. 1998 Oct;120(3):351-6. doi: 10.1016/s0742-8413(98)00039-5. Comp Biochem Physiol C Pharmacol Toxicol Endocrinol. 1998. PMID: 9827050
-
p53 overexpression in formalin-fixed, paraffin-embedded tissue detected by immunohistochemistry.J Histochem Cytochem. 1992 Jul;40(7):1047-51. doi: 10.1177/40.7.1607637. J Histochem Cytochem. 1992. PMID: 1607637
-
[P53 antibodies: a new method for the analysis of alterations of the p53 gene: application to breast cancer].Pathol Biol (Paris). 1996 Apr;44(4):232-4. Pathol Biol (Paris). 1996. PMID: 8763583 Review. French.
Cited by
-
Are there low-penetrance TP53 Alleles? evidence from childhood adrenocortical tumors.Am J Hum Genet. 1999 Oct;65(4):995-1006. doi: 10.1086/302575. Am J Hum Genet. 1999. PMID: 10486318 Free PMC article.
-
Abnormal expression and mutation of p53 in cervical cancer--a study at protein, RNA and DNA levels.Genitourin Med. 1997 Feb;73(1):54-8. doi: 10.1136/sti.73.1.54. Genitourin Med. 1997. PMID: 9155557 Free PMC article.
-
Immunohistochemical detection of p53 and Bcl-2 in colorectal carcinoma: no evidence for prognostic significance.Br J Cancer. 1998 Jun;77(11):1842-7. doi: 10.1038/bjc.1998.306. Br J Cancer. 1998. PMID: 9667656 Free PMC article.
-
Overexpression of p53 protein is an independent prognostic indicator in human endometrial carcinoma.Br J Cancer. 1996 Aug;74(4):562-7. doi: 10.1038/bjc.1996.401. Br J Cancer. 1996. PMID: 8761370 Free PMC article.
-
Immunohistochemical analysis of p53 expression in anal squamous neoplasia.J Clin Pathol. 1993 Jun;46(6):507-12. doi: 10.1136/jcp.46.6.507. J Clin Pathol. 1993. PMID: 8392521 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous